IST:MPARK

MLP Saglik Hizmetleri A.S. · IST · Healthcare · TRY · FY for 2025

Figures on this page computed 2026-11-08 13:21 UTC

Last close

n/aTRY

Market data

14.7xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
TRY
- computed
- Computed from the filing for 2025
14.4%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
TRY
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
10.1%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
TRY
- Computed from the filing for 2025
- Computed from the filing for 2025
3.7%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
TRY
- Computed from the filing for 2025
- Computed from the filing for 2025
0.57Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
TRY
- Computed from the filing for 2025
- Computed from the filing for 2025
0.3%Dividend yield
Source
computed
Taken on
2026-11-08
Reported in
TRY
- computed

Safety is the furthest below its sector's middle: 0.40 against 0.57 on the market's range.

All from 100

lens 2 of 9

Sales

2,989

2015-12-31 to 2025-12-31100 at the start2,989

Sales: 100.00 on 2015-12-31 to 2988.68 on 2025-12-31, up 2889%.

Shares in issue

108

2015-12-31 to 2025-12-31100 at the start108

Shares in issue: 100.00 on 2015-12-31 to 108.25 on 2025-12-31, up 8%.

Profit, where the first year is 100: n/aNot enough filed years carry this line for it to be drawn. No line is drawn flat in its place.

Sales is at 2989, Shares in issue is at 108, against 100 in 2015.

Sales is at 2989, Shares in issue is at 108, against 100 in 2015.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales, where the first year is 1002,989
Source
computed
Statement
income
Fiscal year
2025
Reported in
TRY
Profit, where the first year is 100n/a
Not held.
Source
computed
Statement
income
Fiscal year
2025
Reported in
TRY
Shares in issue, where the first year is 100108
Source
computed
Statement
income
Fiscal year
2025
Reported in
TRY